| [1] |
Xu Fenglin, Wu Gang.
Research progress of EBV in tumor immune microenvironment and immunotherapy of nasopharyngeal carcinoma
[J]. Journal of International Oncology, 2024, 51(6): 359-363.
|
| [2] |
Gu Anqin, Long Jinhua, Jin Feng.
Clinical research progress of immunotherapy for nasopharyngeal carcinoma
[J]. Journal of International Oncology, 2023, 50(5): 299-303.
|
| [3] |
Chen Fangming, Cai Yuanyuan, Li Han, Wang Xiaoli, Kan Hongxing, Li Yang, Hao Furong, Wang Mingchen.
Prognostic differences of nasopharyngeal carcinoma patients treated with intensity-modulated radiothe-rapy with different T staging of the seventh and eighth edition of the UICC staging system
[J]. Journal of International Oncology, 2021, 48(9): 515-522.
|
| [4] |
Peng Ya, Liu An, Liu Huowang.
Inhibitory effect and mechanism of PSD-007 photodynamic therapy on human nasopharyngeal carcinoma transplanted tumors in nude mice
[J]. Journal of International Oncology, 2021, 48(3): 136-142.
|
| [5] |
Zhu Lei, Huang Jianbo.
Effects of Epstein-Barr virus DNA load and different treatment methods on the therapeutic effect and prognosis of stage Ⅲ nasopharyngeal carcinoma
[J]. Journal of International Oncology, 2021, 48(2): 74-79.
|
| [6] |
Luo Wenxiao, Wu Dehua, Cai Longmei.
Prognostic values of immune efficacy biomarkers in the treatment of nasopharyngeal carcinoma
[J]. Journal of International Oncology, 2021, 48(12): 743-746.
|
| [7] |
Yang Minghui, Jin Feng.
Value of 3D-ASL, MRS and DTI in the diagnosis and treatment of radiation-induced temporal lobe injury of nasopharyngeal carcinoma
[J]. Journal of International Oncology, 2020, 47(9): 550-554.
|
| [8] |
Yang Chao, Wang Jianbo, Zhang Juhong, Wang Jialong.
Overexpression of miR-125 inhibits proliferation and invasion of nasopharyngeal carcinoma cells by down-regulating FGF-2
[J]. Journal of International Oncology, 2020, 47(5): 257-263.
|
| [9] |
Shen Jianjun.
Treatment of local recurrenct nasopharyngeal carcinoma after radiotherapy
[J]. Journal of International Oncology, 2020, 47(4): 227-230.
|
| [10] |
Zhou Yuanyuan, Li Jing.
Clinical practice value of hematological inflammation biomarkers in nasopharyngeal carcinoma
[J]. Journal of International Oncology, 2019, 46(8): 492-495.
|
| [11] |
Zhou Ping, Chen Weisi, Zhang Shuang, Lin Bing, Pan Tao, Liu Sha.
Observation of efficacy of paclitaxel with concurrent radiotherapy in the treatment for nasopharyngeal carcinoma patients with liver metastasis
[J]. Journal of International Oncology, 2019, 46(6): 327-330.
|
| [12] |
CHEN Jiong-Yu, ZHUANG Yi-Xuan, ZHUANG Shan-Shan, PENG Lin.
Effects of osthole on the proliferation, invasion and migration of nasopharyngeal carcinoma cells CNE2
[J]. Journal of International Oncology, 2018, 45(8): 453-459.
|
| [13] |
LAI Shi-Jia, ZHAO De-An, SUN Yong-Ming.
Expression and clinical significance of serum microRNA663 in nasopharyngeal carcinoma patients
[J]. Journal of International Oncology, 2018, 45(8): 460-464.
|
| [14] |
Qiao Yunfeng, Li Ping, Fu Zhenming.
Clinical application of cisplatin and nedaplatin
[J]. Journal of International Oncology, 2018, 45(8): 561-565.
|
| [15] |
Huang Ting, Song Xuewei, An Shufen, Wang Zhibin, Liao Hehe.
Expressions of MDR-1 and P-gp in human nasopharyngeal squamous cell carcinoma CNE1 cell line after X-ray exposure
[J]. Journal of International Oncology, 2018, 45(6): 321-324.
|
